Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArgentex Group. Regulatory News (AGFX)

  • This share is currently suspended. It was suspended at a price of 2.45
  • There is currently no data for AGFX

Trading update and Board changes

20 Jan 2021 07:00

RNS Number : 2311M
Argentex Group PLC
20 January 2021
 

20 January 2021

Argentex Group PLC ("Argentex")

Trading update and Board changes

Argentex, the provider of bespoke foreign exchange advisory and execution services to financial institutions, corporates and high net worth individuals today provides a trading update and announces a number of Board changes.

Trading update

Argentex is pleased to report that trading has continued to improve following the announcement of its Interim Results on 20 November 2020. Although the full effect of the latest lockdown has yet to be felt, the recent Brexit trade agreement and the successful implementation of the vaccine programme for Covid-19 provides the Board of Argentex with confidence that this encouraging trend, driven by a return to historic client trading behaviour, will continue for the remainder of the financial year to 31 March 2021.

Board changes

The Board is also pleased to announce the appointment of Jo Stent as Chief Financial Officer with effect from 1 February 2021. She has been a senior finance professional for 25 years, most recently as Chief Financial Officer of the European Tour and Ryder Cup Europe. She is a former CFO of Vodafone Americas having previously held senior positions at Telus Communications and Deloitte. Jo is a chartered accountant having qualified at EY. Jo will replace Sam Williams, who is leaving Argentex to pursue other opportunities, after a handover period of three months.

Carl Jani, Joint CEO, is taking a leave of absence from the business for health reasons with immediate effect. In this interim period, Harry Adams, Joint CEO, will assume the role of sole CEO.

 

Harry Adams, CEO said: "We are delighted to have attracted someone of Jo's calibre to Argentex. Her financial expertise and experience in global businesses will be a huge benefit to us as we continue to realise our growth ambitions. This is an exciting time for us as trading volumes return to pre-pandemic levels."

Lord Digby Jones, Chairman, commented: "I am pleased to welcome Jo to the Board of Argentex where her skills will be a major asset for us as we continue to grow. I'd also like to thank Sam for his dedication and hard work. He joined us in 2015 and was a key member of the team for our successful IPO in 2019. We wish him every success in the future.

"We all wish Carl well and hope he makes a full and speedy recovery."

For further information please contact:

 

FTI Consulting (Financial PR)

Ed Berry / Shiv Talwar / Ambrose Fullalove

Telephone: 07703 330 199

argentex@fticonsulting.com

 

 

Numis Securities Limited (Nominated Adviser and Broker)

Stephen Westgate, Charlie Farquhar, Laura White, Hugo RubinsteinTelephone: +44 (0) 20 7260 1000

 

Additional information:

Joanne Thomson Stent (formerly Fletcher, aged 46) is, or has been, a director or partner of the following companies or partnerships during the previous five years:

 

Current directorships:

Previous directorships (last 5 years):

The National Coaching Foundation

PGA European Tour Productions Limited

 

Fundación Andalusia Valderrama Masters

 

Coachwise Limited

 

Save as set out above there are no other disclosures in respect of the appointment of Jo Stent that fall to be made under Rule 17 or paragraph (g) of Schedule Two of the AIM Rules for Companies.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBLMPTMTJBBLB
Date   Source Headline
2nd Sep 20257:00 amRNSCancellation - Argentex Group PLC
7th Aug 20257:09 amRNSTermination of recommended cash acquisition by IFX
7th Aug 20257:00 amRNSLapsing of Acquisition
1st Aug 20259:37 amRNSResignation of Nominated Adviser and Broker
24th Jul 20253:29 pmRNSAppointment of Administrators
22nd Jul 20258:54 amRNSBoard change
21st Jul 20256:00 pmRNSAppointment of Special Administrators
21st Jul 20257:00 amRNSStatement re recommended acquisition of Argentex
18th Jul 20254:30 pmRNSIntention to Appoint Administrators
18th Jul 20257:00 amRNSAnnouncement of VREQ
17th Jul 20259:46 amRNSForm 8.5 (EPT/RI)
17th Jul 20257:30 amRNSSuspension - Argentex Group plc
17th Jul 20257:00 amRNSUpdate on Financial Position and Suspension
16th Jul 202510:41 amRNSForm 8.5 (EPT/RI)
15th Jul 202511:12 amRNSForm 8.5 (EPT/RI)
15th Jul 20258:57 amRNSForm 8 (DD) - IFX (UK) Ltd
14th Jul 202511:51 amRNSForm 8.5 (EPT/RI)
14th Jul 202510:24 amRNSForm 8 (DD) - IFX (UK) Ltd
11th Jul 202512:01 pmRNSForm 8.5 (EPT/RI)
10th Jul 202510:55 amRNSForm 8.5 (EPT/RI)
9th Jul 20259:48 amRNSForm 8.5 (EPT/RI)
9th Jul 20258:12 amRNSForm 8 (DD) - Argentex Group PLC
8th Jul 202510:47 amRNSForm 8.5 (EPT/RI)
8th Jul 20258:48 amRNSForm 8 (DD) - IFX (UK) Ltd
8th Jul 20257:00 amRNSAmendment to RCF & Announcement of VREQ
4th Jul 202510:04 amRNSForm 8.5 (EPT/RI)
3rd Jul 202512:11 pmRNSForm 8.5 (EPT/RI)
2nd Jul 202512:07 pmRNSForm 8.5 (EPT/RI)
1st Jul 202511:16 amRNSForm 8.5 (EPT/RI)
30th Jun 20254:43 pmRNSForm 8 (DD) - IFX (UK) Ltd - AMEND
30th Jun 202511:35 amRNSForm 8.5 (EPT/RI)
30th Jun 20259:48 amRNSForm 8 (DD) - IFX (UK) Ltd
27th Jun 202510:33 amRNSForm 8 (DD) - Argentex Group PLC
27th Jun 202510:03 amRNSForm 8.5 (EPT/RI)
26th Jun 202512:00 pmRNSAnnouncement of VREQ
26th Jun 202511:57 amRNSForm 8.5 (EPT/RI)
26th Jun 20259:13 amRNSForm 8 (DD) - Argentex Group PLC
25th Jun 202510:09 amRNSForm 8.5 (EPT/RI)
25th Jun 202510:08 amRNSForm 8 (DD) - Argentex Group PLC
24th Jun 202510:01 amRNSForm 8.5 (EPT/RI) Argentex Group PLC
23rd Jun 202510:33 amRNSForm 8 (DD) - Argentex Group PLC
23rd Jun 202510:12 amRNSForm 8.5 (EPT/RI)
20th Jun 202511:13 amRNSForm 8 (DD) - Argentex Group PLC
20th Jun 202510:09 amRNSForm 8.5 (EPT/RI)
19th Jun 202512:02 pmRNSForm 8.5 (EPT/RI)
18th Jun 202512:02 pmRNSForm 8.5 (EPT/RI)
17th Jun 20259:52 amRNSForm 8.5 (EPT/RI)
16th Jun 20259:19 amRNSForm 8.5 (EPT/RI)
13th Jun 202512:06 pmRNSForm 8.5 (EPT/RI)
12th Jun 202511:57 amRNSForm 8.5 (EPT/RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.